Tag Archives: reimbursement

Guest BlogSpot – Which Drugs are the Most Innovative?

Posted on November 29, 2010 by Barbara Arzymanow

Andrew Lansley has recently said: “I am determined that not only will we have a reimbursement price for medicines which reflects their benefit to patients, but also one which incentivises for innovation, and supports those new medicines which respond to … Continue reading →

Posted in Andrew Lansley, Department of Health, Drugs, Emerging technologies, NHS, Policy, Research, Technology, Uncategorized | Tagged 2020health, breakthrough, Department of Health, drug pricing, Drugs, health, innovation, innovative, medicine, outcomes, patient, pharmaceutical, R & D, reimbursement, Research, unmet clinical need, unmet healthcare need, value-based pricing | Leave a comment

	Lali Sekhon, MD on Tackling obesity – What the UK…
	Author Ingrid Hall on Ovarian Cancer – Make wo…
	David Bradley on 2020health comments on GMC rep…
	20 things to make yo… on Equal treatment for Depression…
	David Bradley on Guest Blogspot: Misleading, Bi…

Tag Archives: reimbursement

Guest BlogSpot – Which Drugs are the Most Innovative?

TwentyTwentyTweets

Email Subscription

Recent Posts

Pages

Opinions

Categories